IQVIA Report: "Clinical Trial Shares Decline in Europe, Surge in North America and China"

"Global Clinical Trials Shift from Europe to US and China"

The focus of global clinical trials is shifting from Europe to the United States and China, according to a recent market analysis. IQVIA, a global healthcare consulting firm, released a…

Market Share Drops to 82% in May... Challenges from Samsung Bioepis and Celltrion

Biosimilar Onslaught Dents Global Blockbuster Humira

The dominance of the autoimmune disease treatment Humira (active ingredient: adalimumab), once the world's best-selling drug, is waning. Sandoz's biosimilar Hyrimoz has rapidly gained market share,…

Epkinly Approved as Third-Line Treatment for Diffuse Large B-Cell Lymphoma in Korea

A New Treatment Option Emerges for Non-Hodgkin's Lymphoma

A new treatment option for managing refractory blood cancer, specifically Diffuse Large B-Cell Lymphoma (DLBCL), has completed its approval process in Korea. This approval primarily…